Clinical trial
Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke…
NCT00413595 · CENTOGENE GmbH Rostock, Industry · Completed
Key facts
| NCT number | NCT00413595 |
|---|---|
| Title | Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation |
| Official title | Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation in Young Patients With Fabry Disease: An Epidemiological, International, Multicenter Prognosis Study |
| Acronym | sifap2 |
| Lead sponsor | CENTOGENE GmbH Rostock, Industry |
| Collaborators | Shire Human Genetic Therapies, Inc. Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Fabry Disease, Cerebrovascular Accident |
| Intervention type | Other |
| Interventions | No intervention |
| Enrollment | 100 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2019 |
| Completion | Dec 1, 2019 |
| First posted | Dec 20, 2006 |
| Last update posted | Apr 12, 2021 |
| Countries | Austria, Croatia, France, Georgia, Germany, Poland, Portugal |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: